Telomir Pharmaceuticals, Inc

PRESS RELEASE

published on 10/09/2025 at 13:30, 10 months 20 days ago

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
Telomir Pharmaceuticals announces new findings showing Telomir-1's impact on aggressive breast cancer cells, targeting iron-dependent regulation and cellular energy pathways

Telomir-1 Telomir Pharmaceuticals Breast Cancer Cells Iron-dependent Regulation Cellular Energy Pathways
BRIEF

published on 10/07/2025 at 13:35, 10 months 22 days ago

Telomir Pharmaceuticals dévoile des résultats précliniques prometteurs dans le traitement du cancer de la prostate

Cancer De La Prostate Telomir-1 Telomir Pharmaceuticals Thérapie Épigénétique Suppresseurs De Tumeurs
BRIEF

published on 10/07/2025 at 13:35, 10 months 22 days ago

Telomir Pharmaceuticals Unveils Promising Preclinical Results in Prostate Cancer Therapy

Prostate Cancer Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy Tumor Suppressors
PRESS RELEASE

published on 10/07/2025 at 13:30, 10 months 22 days ago

Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
Telomir Pharmaceuticals unveils new preclinical findings showing Telomir-1 reactivates tumor suppressor genes MASPIN and RASSF1A in aggressive prostate cancer models, offering potential for improved chemotherapy response and metastasis control

Prostate Cancer Telomir-1 Telomir Pharmaceuticals Preclinical Findings Tumor Suppressor Genes
BRIEF

published on 09/18/2025 at 14:05, 11 months 11 days ago

Telomir-1 Shows Expanded Targeting of Histone Demethylases

Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy Histone Demethylases Cancer And Aging
BRIEF

published on 09/18/2025 at 14:05, 11 months 11 days ago

Telomir-1 montre un ciblage élargi des déméthylases d'histones

Telomir-1 Telomir Pharmaceuticals Thérapie Épigénétique Histone Demethylases Cancer Et Vieillissement
PRESS RELEASE

published on 09/18/2025 at 14:00, 11 months 11 days ago

Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies
Telomir Pharmaceuticals announces Telomir-1's new in vitro results inhibiting KDM5 family, expanding epigenetic therapy possibilities in cancer treatment and aging slowdown

Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy KDM5 Family Inhibition Cancer Aging Treatment
BRIEF

published on 09/09/2025 at 14:05, 11 months 20 days ago

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data

Cancer Research Telomir-1 Telomir Pharmaceuticals DNA Methylation CDKN2A
BRIEF

published on 09/09/2025 at 14:05, 11 months 20 days ago

Telomir Pharmaceuticals dévoile des données précliniques prometteuses sur le cancer

Telomir-1 Telomir Pharmaceuticals Recherche Sur Le Cancer Méthylation De L'ADN CDKN2A
PRESS RELEASE

published on 09/09/2025 at 14:00, 11 months 20 days ago

Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
Telomir Pharmaceuticals announces new preclinical findings showing Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, potentially restoring cancer cell cycle control and immune surveillance

Cancer Therapy Telomir Pharmaceuticals Preclinical Findings DNA Methylation CDKN2A Gene

Published on 08/29/2026 at 05:15, 15 hours 22 minutes ago

Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 17 hours 17 minutes ago

BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 19 hours 22 minutes ago

Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/29/2026 at 01:00, 19 hours 37 minutes ago

Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Published on 08/28/2026 at 23:00, 21 hours 37 minutes ago

Guanajuato Silver Grants Stock Options to Officer

View all ACCESSWIRE

Published on 08/29/2026 at 04:05, 16 hours 32 minutes ago

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Published on 08/28/2026 at 20:49, 23 hours 47 minutes ago

Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 23 hours 55 minutes ago

Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 1 day 1 hour ago

Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 1 day 2 hours ago

CPI Europe announces unaudited results for the first half of 2026

View all EQS

Published on 08/28/2026 at 18:27, 1 day 2 hours ago

Droits de vote au 31-07-2026
Published on 08/28/2026 at 18:25, 1 day 2 hours ago

Droits de vote au 30-06-2026
Published on 08/28/2026 at 17:45, 1 day 2 hours ago

STEF : Droits de vote au 31 07 2026
Published on 08/28/2026 at 06:55, 1 day 13 hours ago

Recticel Accelerates Profitable Growth
Published on 08/28/2026 at 06:55, 1 day 13 hours ago

Recticel versnelt winstgevende groei

View all LES ECHOS COMFI WIRE

News